| Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? TJ Price, C Beeke, S Ullah, R Padbury, G Maddern, D Roder, ... Cancer 121 (6), 830-835, 2015 | 170 | 2015 |
| Role of aquaporin 1 signalling in cancer development and progression Y Tomita, H Dorward, AJ Yool, E Smith, AR Townsend, TJ Price, ... International journal of molecular sciences 18 (2), 299, 2017 | 105 | 2017 |
| The Purified Extract from the Medicinal Plant Bacopa monnieri, Bacopaside II, Inhibits Growth of Colon Cancer Cells In Vitro by Inducing Cell Cycle Arrest and … E Smith, HM Palethorpe, Y Tomita, JV Pei, AR Townsend, TJ Price, ... Cells 7 (7), 81, 2018 | 54 | 2018 |
| Ginsenoside Rg3: Potential molecular targets and therapeutic indication in metastatic breast cancer M Nakhjavani, JE Hardingham, HM Palethorpe, Y Tomita, E Smith, ... Medicines 6 (1), 17, 2019 | 44 | 2019 |
| The aquaporin 1 inhibitor bacopaside II reduces endothelial cell migration and tubulogenesis and induces apoptosis HM Palethorpe, Y Tomita, E Smith, JV Pei, AR Townsend, TJ Price, ... International journal of molecular sciences 19 (3), 653, 2018 | 43 | 2018 |
| Bacopasides I and II act in synergy to inhibit the growth, migration and invasion of breast cancer cell lines HM Palethorpe, E Smith, Y Tomita, M Nakhjavani, AJ Yool, TJ Price, ... Molecules 24 (19), 3539, 2019 | 38 | 2019 |
| Stereoselective anti-cancer activities of ginsenoside Rg3 on triple negative breast cancer cell models M Nakhjavani, HM Palethorpe, Y Tomita, E Smith, TJ Price, AJ Yool, ... Pharmaceuticals 12 (3), 117, 2019 | 37 | 2019 |
| A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy T Krishnan, Y Tomita, R Roberts-Thomson Future Science OA 6 (10), FSO608, 2020 | 27 | 2020 |
| Salvage systemic therapy for advanced gastric and oesophago‐gastric junction adenocarcinoma Y Tomita, M Moldovan, RC Lee, AHC Hsieh, A Townsend, T Price Cochrane Database of Systematic Reviews, 2020 | 23 | 2020 |
| Young‐onset colorectal cancer is associated with a personal history of type 2 diabetes RR Mikaeel, EL Symonds, J Kimber, E Smith, M Horsnell, W Uylaki, ... Asia‐Pacific Journal of Clinical Oncology 17 (1), 131-138, 2021 | 22 | 2021 |
| Bumetanide-derived aquaporin 1 inhibitors, AqB013 and AqB050 inhibit tube formation of endothelial cells through induction of apoptosis and impaired migration in vitro Y Tomita, HM Palethorpe, E Smith, M Nakhjavani, AR Townsend, TJ Price, ... International Journal of Molecular Sciences 20 (8), 1818, 2019 | 20 | 2019 |
| Findings in young adults at colonoscopy from a hospital service database audit S Wong, I Lidums, C Rosty, A Ruszkiewicz, S Parry, AK Win, Y Tomita, ... BMC gastroenterology 17, 1-9, 2017 | 20 | 2017 |
| High early growth response 1 (EGR1) expression correlates with resistance to anti-EGFR treatment in vitro and with poorer outcome in metastatic colorectal cancer patients … SS Kumar, Y Tomita, J Wrin, M Bruhn, A Swalling, M Mohammed, TJ Price, ... Clinical and Translational Oncology 19, 718-726, 2017 | 18 | 2017 |
| Anti-angiogenic properties of ginsenoside Rg3 epimers: In vitro assessment of single and combination treatments M Nakhjavani, E Smith, K Yeo, HM Palethorpe, Y Tomita, TJ Price, ... Cancers 13 (9), 2223, 2021 | 16 | 2021 |
| Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry Y Tomita, CS Karapetis, S Ullah, AR Townsend, D Roder, C Beeke, ... Acta Oncologica 55 (4), 480-485, 2016 | 14 | 2016 |
| Survey of germline variants in cancer‐associated genes in young adults with colorectal cancer RR Mikaeel, JP Young, Y Li, E Smith, M Horsnell, W Uylaki, G Tapia Rico, ... Genes, Chromosomes and Cancer 61 (2), 105-113, 2022 | 12 | 2022 |
| Anti-cancer effects of an optimised combination of ginsenoside Rg3 epimers on triple negative breast cancer models M Nakhjavani, E Smith, HM Palethorpe, Y Tomita, K Yeo, TJ Price, ... Pharmaceuticals 14 (7), 633, 2021 | 8 | 2021 |
| Reduced aquaporin-1 transcript expression in colorectal carcinoma is associated with promoter hypermethylation E Smith, Y Tomita, HM Palethorpe, S Howell, M Nakhjavani, ... Epigenetics 14 (2), 158-170, 2019 | 8 | 2019 |
| Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis CMY Li, Y Tomita, B Dhakal, R Li, J Li, P Drew, T Price, E Smith, ... Journal for Immunotherapy of Cancer 11 (4), 2023 | 7 | 2023 |
| Appendiceal neoplasm incidence and mortality rates are on the rise in Australia RR Mikaeel, JP Young, JE Hardingham, G Tapia Rico, PJ Hewett, ... Expert review of gastroenterology & hepatology 15 (2), 203-210, 2021 | 7 | 2021 |
